A doctor has urged patients to proceed with caution when using cannabis during cancer immunotherapy and called for more ...

In a time of increasing cannabis acceptance and use, cannabis hyperemesis syndrome has emerged. While relatively rare, total ...

HealthDay News — Only 36.8 percent of adolescents diagnosed with cannabis use disorder (CUD) complete treatment, according to a study published online July 22 in Pediatric Reports.

Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment ...

A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with ...

The largest (self-selected) survey of  people living with eating disorders has revealed some surprising insights into how ...

Cannabis use disorder in adolescents in the United States remains a growing threat despite declines in cannabis use.

Subgroup analysis suggested that cannabinoids, compared with the control, were associated with a higher risk of serious adverse events in trials of only children and adolescents (RR 1.87, 95% CI 1 ...

But overall, our findings suggest cannabinoids may acutely influence sleep, primarily by suppressing REM sleep, without ...

InMed Pharma is developing a potential Alzheimer's treatment with neuroprotective and anti-inflammatory effects. Expert collaboration and a multifaceted approach show promise for better patient ...